Abstract
ABH antigens are not expressed on the red blood cells (RBCs) of monkeys, making it difficult to accurately determine their blood type using standard human protocols. In this study, we evaluated the feasibility, convenience, and stability of two non-invasive methods for ABO typing in cynomolgus monkeys (n = 72): a reverse gel system assay and a buccal mucosal cell immunofluorescent assay. Using renal tissue immunofluorescent assay as the gold standard, we found that the reverse gel system assay achieved accurate detection in 65 of the 72 monkeys (90.3%). The buccal mucosal cell immunofluorescent assay correctly identified the ABO blood groups in 50 monkeys on the first attempt, but reached 100% accuracy after repeated sampling for difficult cases. Based on our findings, we recommend the reverse gel system assay as the primary screening tool, with the buccal mucosal cell assay serving as a definitive supplementary method when serum results are ambiguous.
Introduction
In human medicine, blood typing is straightforward because ABH antigens are expressed directly on the surface of red blood cells. However, in non-human primates like cynomolgus monkeys (Macaca fascicularis), these antigens are absent or weakly expressed on RBCs, residing instead in vascular endothelium, epithelial cells, and secretions. This creates a significant hurdle for researchers in fields like organ transplantation and hematology, where knowing the blood type is vital to prevent hyperacute rejection. While invasive tissue biopsies can provide definitive typing, there is a critical need for reliable, non-invasive methods to type live animals without surgical intervention.
Methods
The researchers compared two non-invasive techniques against a "gold standard" invasive renal tissue biopsy in a cohort of 72 male cynomolgus monkeys:
- Reverse Gel System Assay (Indirect): This method detects anti-A or anti-B antibodies in the monkey's serum rather than antigens on their cells. To prevent false positives from non-specific antibodies, the serum is "preabsorbed" using human Type O RBCs and then tested in a standardized microtube gel card.
- Buccal Mucosal Cell Immunofluorescent Assay (Direct): This involves taking a cheek swab and using fluorescently labeled antibodies to detect A or B antigens directly on the epithelial cells.
- Renal Tissue Staining (Control): Immunofluorescent staining of kidney tissue established the definitive blood type for each monkey to measure the accuracy of the non-invasive methods.
Results and Discussion
The study cohort provided a representative distribution of blood types: Type B (41.7%), Type AB (29.2%), Type A (27.8%), and Type O (1.3%).
The Reverse Gel System Assay achieved a 90.3% coincidence rate with the gold standard. It was fast and clear for the majority of subjects but failed to give a definitive answer for 7 monkeys. This "serum interference" is likely due to unknown non-specific proteins or antibodies that the pre-absorption step could not eliminate.
The Buccal Mucosal Assay initially identified 69.4% of monkeys correctly. The primary limitation of this method is its susceptibility to sample quality; food particles, impurities, or insufficient cell counts can lead to unreadable slides. However, after repeated smearing and staining for difficult cases, this method reached 100% accuracy. Unlike the serum-based assay, the buccal smear is a direct method, making it theoretically more robust against the biochemical interferences found in monkey blood.
Conclusion
The reverse gel assay is highly standardized and easily implemented in most laboratory settings, whereas the buccal mucosal assay is technically demanding and requires specialized expertise. Therefore, we suggest a tiered workflow: the Reverse Gel System should be the first choice for routine screening. If the results are ambiguous, the Buccal Mucosal Assay should be used as the definitive supplementary method to ensure accurate blood group identification.
Summary updated